Last checked at 5 Jan 2022 07:00
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
MyHealthChecked Plc
("MyHealthChecked", "MHC" or the "Company")
Retail partnership with Lloyds Pharmacy for COVID-19 Antigen testing
MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company, has signed a contract with AAH Pharmaceuticals Limited ("Lloyds Pharmacy") for supply of the Fit to Fly/Pre-departure rapid antigen test. The test can be taken at home prior to travel, or overseas prior to returning to the UK, with results verified by a trained professional within two hours of completing the test, and provides the passenger with a certificate suitable for outbound or return travel.
The rapid antigen tests and accompanying verification service provided by MyHealthChecked will be the only COVID rapid antigen test sold through Lloyds Pharmacy and will accompany the portfolio of PCR kits that the pharmacy began selling online in August.
The Fit to Fly rapid tests will launch at Lloyds Pharmacy in January 2022.
Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said:
"I am pleased to build on our existing relationship with Lloyds Pharmacy with our new COVID-19 antigen test service for travel. Lloyds Pharmacy is already well established with a PCR testing portfolio that includes inbound PCR testing for fully vaccinated and non-vaccinated customers. We are delighted to be supporting Lloyds Pharmacy further with their growing COVID testing portfolio and working with them as testing protocols for travel continue to evolve."
MyHealthChecked plc | www.myhealthchecked.com | |
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
Gareth Davies, Chief Financial and Operations Officer | ||
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)203 179 5344 | |
Mike Seabrook | mikeseabrook@oberoninvestments.com | |
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com | |
Paul McManus / Alice Woodings | Mob: +44(0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests. MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests, now in development following the acquisition of The Genome Store in November 2020. The tests will be made available online, and would be viable for over the counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.